Javascript must be enabled to continue!
Resectable Remnant Gastric Cancer: Worse Prognosis or Unsuitable Stage Classification System? A Retrospective Propensity Score Matching Analysis
View through CrossRef
Abstract
Purpose: Currently, the characteristics, and prognosis of remnant gastric cancer (RGC) were not fully understood yet. The present study aimed to describe the details of clinicopathological features of resectable RGC and investigated the factors affecting survival after the curative operation.Methods: From Jan. 2006 to Dec. 2015, a total of 118 resectable RGC patients (the RGC group) and 236 age-, sex- and TNM stages matched resectable gastric cancer (GC) patients (the control group) were recruited retrospectively. Clinicopathological characteristics and overall survival were compared between the two groups.Results: The overall survival rate was 46.61% for RGC patients compared to 55.08% for control groups (P < 0.01), and the mean overall survival time of RGC patients was 40.23 ± 32.27 months, compared with 55.06 ± 34.29 months in the control group (P = 0.023 after matching). The overall survival (OS) of RGC patients with stage IIb was much worse than IIa (P < 0.001) and similar to Ⅲa (P = 0.463) and Ⅲb (P = 0.014 ), which indicated that the current TNM classification was not suitable for the patients with RGC. Multivariate Cox proportional hazards model analysis revealed that TNM stage (HR: 3.899, P < 0.001) and metastatic lymph nodes ratio (LNR) (HR: 2.405, P = 0.028) were independent prognostic significance to OS.Conclusions: The OS of RGC was much worse than GC with similar TNM stages, which might be caused by an unsuitable TNM stage classification system for RGC. And LNR might consider a highly reliable indicator to evaluate the N status in RGC.
Research Square Platform LLC
Title: Resectable Remnant Gastric Cancer: Worse Prognosis or Unsuitable Stage Classification System? A Retrospective Propensity Score Matching Analysis
Description:
Abstract
Purpose: Currently, the characteristics, and prognosis of remnant gastric cancer (RGC) were not fully understood yet.
The present study aimed to describe the details of clinicopathological features of resectable RGC and investigated the factors affecting survival after the curative operation.
Methods: From Jan.
2006 to Dec.
2015, a total of 118 resectable RGC patients (the RGC group) and 236 age-, sex- and TNM stages matched resectable gastric cancer (GC) patients (the control group) were recruited retrospectively.
Clinicopathological characteristics and overall survival were compared between the two groups.
Results: The overall survival rate was 46.
61% for RGC patients compared to 55.
08% for control groups (P < 0.
01), and the mean overall survival time of RGC patients was 40.
23 ± 32.
27 months, compared with 55.
06 ± 34.
29 months in the control group (P = 0.
023 after matching).
The overall survival (OS) of RGC patients with stage IIb was much worse than IIa (P < 0.
001) and similar to Ⅲa (P = 0.
463) and Ⅲb (P = 0.
014 ), which indicated that the current TNM classification was not suitable for the patients with RGC.
Multivariate Cox proportional hazards model analysis revealed that TNM stage (HR: 3.
899, P < 0.
001) and metastatic lymph nodes ratio (LNR) (HR: 2.
405, P = 0.
028) were independent prognostic significance to OS.
Conclusions: The OS of RGC was much worse than GC with similar TNM stages, which might be caused by an unsuitable TNM stage classification system for RGC.
And LNR might consider a highly reliable indicator to evaluate the N status in RGC.
Related Results
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
4060 Background: Gastric cancer is one of the most common cancer types. Most patients were diagnosed at advanced stages and experienced poor prognosis. A non-invasive assay for th...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract
Introduction
Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer
LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer
Background and Objective: Gastric cancer (GC) is a common tumor malignancy with high incidence and poor prognosis. Laminin is an indispensable component of basement membrane and ex...
Identification and Validation of an Individualized Autophagy-Clinical Prognostic Index in Gastric Cancer Patients
Identification and Validation of an Individualized Autophagy-Clinical Prognostic Index in Gastric Cancer Patients
Abstract
Background: The purpose of this study is to perform bioinformatics analysis of autophagy-related genes in gastric cancer, and to construct a multi-gene joint signa...
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract
Background: The associations of multiple autoimmune conditions with gastric cancer may reflect their co-occurrence with autoimmune gastritis and its clinica...
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
<div>Abstract<p>The hyaluronan-mediated motility receptor (HMMR) is overexpressed in gastric cancer; however, the apparent role of HMMR has not been well defined owing ...
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
Data from Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer
<div>Abstract<p>The hyaluronan-mediated motility receptor (HMMR) is overexpressed in gastric cancer; however, the apparent role of HMMR has not been well defined owing ...
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
AbstractObjectiveGastric carcinoma is the most common malignant tumour of the human digestive system worldwide. CD44 serves as a marker for several tumour stem cells, including gas...

